Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-036528
Filing Date
2017-07-12
Accepted
2017-07-12 13:44:48
Documents
6
Period of Report
2017-08-29
Effectiveness Date
2017-07-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A v470646_def14a.htm DEF 14A 537513
2 GRAPHIC pg1img1_proxy.jpg GRAPHIC 2196
3 GRAPHIC pg1img2_proxy.jpg GRAPHIC 1828
4 GRAPHIC pg1img3_proxy.jpg GRAPHIC 1930
5 GRAPHIC pg1img4_proxy.jpg GRAPHIC 1593
6 GRAPHIC pg2img01_def14a.jpg GRAPHIC 3864
  Complete submission text file 0001144204-17-036528.txt   555246
Mailing Address 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL 32202
Business Address 50 N LAURA STREET SUITE 2500 JACKSONVILLE FL 32202 (904) 516-5436
TAPIMMUNE INC. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37939 | Film No.: 17961561
SIC: 2834 Pharmaceutical Preparations